Home > Annual Financials > ROSSARI BIOTECH

ROSSARI BIOTECH Financial Statement Analysis
[BOM: 543213|NSE : ROSSARI]

The Revenues of ROSSARI BIOTECH have increased by 11.66% YoY .
The Earnings Per Share (EPS) of ROSSARI BIOTECH has increased by 21.65 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

ROSSARI BIOTECH Last 5 Annual Financial Results
[BOM: 543213|NSE : ROSSARI]

ConsolidatedMar2024
Mar2023
Mar2022
Mar2021
Mar2020
Revenues ₹1,656 Cr₹1,483 Cr₹709 Cr₹600 Cr₹516 Cr
Expenses ₹1,441 Cr₹1,307 Cr₹586 Cr₹495 Cr₹439 Cr
Operating Profit (Excl OI) ₹215 Cr₹176 Cr₹123 Cr₹105 Cr₹78 Cr
Other Income ₹14 Cr₹19 Cr₹9.19 Cr₹3.72 Cr₹0.91 Cr
Interest ₹22 Cr₹13 Cr₹2.99 Cr₹3.56 Cr₹2.88 Cr
Depreciation ₹63 Cr₹48 Cr₹23 Cr₹17 Cr₹12 Cr
Profit Before Tax ₹144 Cr₹136 Cr₹107 Cr₹88 Cr₹63 Cr
Profit After Tax ₹107 Cr₹98 Cr₹80 Cr₹65 Cr₹46 Cr
Consolidated Net Profit ₹107 Cr₹98 Cr₹80 Cr₹65 Cr₹46 Cr
Earnings Per Share (Rs)₹23.66₹19.45₹17.74₹15.45₹12.86
PAT Margin (%)7.116.456.5611.1910.82
ROE(%)13.3612.5216.1723.1131.83
ROCE(%)18.3918.4824.3728.8137.93
Total Debt/Equity(x)0.100.080.010.000.23

Key Financials

Market Cap : ₹ 4,846.2 Cr
Revenue (TTM) : ₹ 1,909.6 Cr
Net Profit(TTM) : ₹ 135.9 Cr
EPS (TTM) : ₹ 24.6
P/E (TTM) : 35.7

Industry Peers & Returns1W1M1Y
ROSSARI BIOTECH -4.3% -1.7% 9.7%
PIDILITE INDUSTRIES -4.5% -0.1% 35.2%
SOLAR INDUSTRIES INDIA -6.1% -0.9% 136.4%
SRF -4.6% -9.7% 7.6%
GUJARAT FLUOROCHEMICALS -5.4% 28.4% 40.2%
DEEPAK NITRITE -2.4% -5.4% 36.3%


ROSSARI BIOTECH Revenues
[BOM: 543213|NSE : ROSSARI]

Y-o-Y

11.66 %

5 Yr CAGR

33.83 %

Years Revenues % Change
Mar2024 ₹1,656 Cr
11.66
Mar2023 ₹1,483 Cr
109.06
Mar2022 ₹709 Cr
18.21
Mar2021 ₹600 Cr
16.25
Mar2020 ₹516 Cr -


ROSSARI BIOTECH Operating Profit
[BOM: 543213|NSE : ROSSARI]

Y-o-Y

21.70 %

5 Yr CAGR

28.97 %

Years Operating Profit % Change
Mar2024 ₹215 Cr
21.70
Mar2023 ₹176 Cr
43.26
Mar2022 ₹123 Cr
17.48
Mar2021 ₹105 Cr
35.06
Mar2020 ₹78 Cr -

Operating Margins
Y-o-Y

9.00 %

5 Yr CAGR

-3.62 %

Years Operating Margin% % Change
Mar2024 12.96%
9.00
Mar2023 11.89%
-31.47
Mar2022 17.35%
-0.57
Mar2021 17.45%
16.18
Mar2020 15.02% -

ROSSARI BIOTECH Profit After Tax
[BOM: 543213|NSE : ROSSARI]

Y-o-Y

9.81 %

5 Yr CAGR

23.78 %

Years Profit After Tax % Change
Mar2024 ₹107 Cr
9.81
Mar2023 ₹98 Cr
21.76
Mar2022 ₹80 Cr
22.94
Mar2021 ₹65 Cr
42.84
Mar2020 ₹46 Cr -

PAT Margins
Y-o-Y

10.23 %

5 Yr CAGR

-9.97 %

Years PAT Margin(%) % Change
Mar2024 7.11 %
10.23
Mar2023 6.45 %
-1.68
Mar2022 6.56 %
-41.38
Mar2021 11.19 %
3.42
Mar2020 10.82 % -

ROSSARI BIOTECH Earnings Per Share (EPS)
[BOM: 543213|NSE : ROSSARI]

Y-o-Y

21.65 %

5 Yr CAGR

16.46 %

Years EPS % Change
Mar2024 ₹24
21.65
Mar2023 ₹19
9.64
Mar2022 ₹18
14.82
Mar2021 ₹15
20.14
Mar2020 ₹13 -

ROSSARI BIOTECH Return on Capital Employed (ROCE)
[BOM: 543213|NSE : ROSSARI]

Y-o-Y

-0.49 %

5 Yr CAGR

-16.56 %

Years ROCE % Change
Mar2024 18.39%
-0.49
Mar2023 18.48%
-24.17
Mar2022 24.37%
-15.41
Mar2021 28.81%
-24.04
Mar2020 37.93% -

ROSSARI BIOTECH Share Price vs Sensex

Current Share Price : ₹876.4
Current MarketCap: ₹ 4,846.2 Cr
Updated EOD on :Oct 04,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
ROSSARI BIOTECH

-4.3%

-1.7%

9.7%

SENSEX

-4.8%

-1.1%

24.7%

ROSSARI BIOTECH related INDICES

BSE Indices1W1M1Y
S&P BSE BASIC MATERIALS -0.4% 4.3% 39.3%
S&P BSE SMALL CAP -1.9% -0.2% 49.8%
S&P BSE MIDSMALLCAP -2.4% -1.3% 50%
S&P BSE ALLCAP -3.8% -1.2% 37.3%
No NSE index found

You may also like the below Video Courses


FAQ about ROSSARI BIOTECH Financials


How the annual revenues of ROSSARI BIOTECH have changed ?

The Revenues of ROSSARI BIOTECH have increased by 11.66% YoY .

How the Earnings per Share (EPS) of ROSSARI BIOTECH have changed?

The Earnings Per Share (EPS) of ROSSARI BIOTECH has increased by 21.65 % YoY .